Roman Анатольевич Chernikov

Dr. Roman Анатольевич Chernikov

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2018 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
PKPolina Knyazeva
Polina Knyazeva
VMViktor Makarin
Viktor Makarin
BSBarbara Seeliger
Barbara Seeliger
RCRoman Анатольевич Chernikov
Roman Анатольевич Chernikov
ISIlya Sleptsov
Ilya Sleptsov
PAPier Francesco Alesina
Pier Francesco Alesina

7 July 2017 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
DBDmitry G. Beltsevich
Dmitry G. Beltsevich
VVVladimir E. Vanushko
Vladimir E. Vanushko
PRPavel O. Rumiantsev
Pavel O. Rumiantsev
GMGalina A. Melnichenko
Galina A. Melnichenko
NKNikolay S. Kuznetsov
Nikolay S. Kuznetsov
ВЛВоробьев Сергей Леонидович
Воробьев Сергей Леонидович
В представленных клинических рекомендациях обсуждаются современные подходы к диагностике и лечению дифференцированного рака щитовидной железы у взрослых. Изменения в настоящей редакции Клинических рекомендаций касаются показаний к пункционной биопсии, скринингового определения концентрации кальцитонина, унификации заключений цитологического исследования, новых подходах к послеоперационной динамической стратификации риска рецидива, показаний к супрессивной и заместительной терапии, таргетной терапии йоднегативных форм дифференцированного рака щитовидной железы.

11 January 2021 in Cancers
Verified
Journal Article
Open access
PDF file
STSergei Titov
Sergei Titov
EKEVGENIYA KOZOREZOVA
EVGENIYA KOZOREZOVA
PDPavel S. Demenkov
Pavel S. Demenkov
JVJulia Veryaskina
Julia Veryaskina
IKIrina V. Kuznetsova
Irina V. Kuznetsova
MIMikhail K Ivanov
Mikhail K Ivanov
In previous studies, we described a method for detecting and typing malignant tumors of the thyroid gland in fine-needle aspiration biopsy samples via analysis of a molecular marker panel (normalized HMGA2 mRNA level; normalized microRNA-146b, -221, and -375 levels; mitochondrial-to-nuclear DNA ratio; and BRAFV600E mutation) in cytological preparations by quantitative PCR. In the present study, we aimed to estimate the specificity of the typing of different thyroid tumors by the proposed method. Fine-needle aspiration cytological preparations from 278 patients were used. The histological diagnosis was known for each sample. The positive and negative predictive values of the method assessed in this study were, respectively, 100% and 98% for papillary thyroid carcinoma (n = 63), 100% and 100% for medullary thyroid carcinoma (n = 19), 43.5% and 98% for follicular carcinoma (n = 15), and 86% and 100% for Hürthle cell carcinoma (n = 6). Thus, we demonstrate that the diagnostic panel, including the analysis of microRNA expression, mRNA expression, the BRAFV600E mutation, and the mitochondrial-to-nuclear DNA ratio, allows the highly accurate identification of papillary thyroid carcinoma, medullary thyroid carcinoma, and Hürthle cell carcinoma but not malignant follicular tumors (positive predictive value was below 50%).

21 April 2023 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
TITatyana Ionova
Tatyana Ionova
DBD. M. Buzanakov
D. M. Buzanakov
RCRoman Анатольевич Chernikov
Roman Анатольевич Chernikov
SESergey M. Efremov
Sergey M. Efremov
IGI. N. Gladkova
I. N. Gladkova
VRV. F. Rusakov
V. F. Rusakov
Background: Primary hyperparathyroidism (PHPT) is a common endocrine disorder caused by a parathyroid tumor or hyperplasia, which is often accompanied with quality of life (QoL) impairment. A parathyroidectomy (PTX) is the preferred standard treatment for PHPT patients. In this single center study we aimed to evaluate the impact of PHPT on patient’s QoL and identify QoL changes at early and long-term follow-up after surgery. Methods: All the patients underwent routine PTX with the removal of the suspected hyperparathyroid gland(s). Patients filled out generic QoL questionnaire RAND SF-36, specific questionnaire PHPQoL and specific symptom assessment questionnaire PAS upon admission to the hospital before surgery, at 3 months, 12 months and 24 months after surgery. Results: A total of 92 patients with PHPT (median age was 56 years, 95.7% females) were included in the study. Before PTX patient’s QoL by SF-36 scores was significantly lower as compared to healthy controls (p < 0.01). Almost 40% of patients had poor or very poor QoL. The most frequent symptoms by PAS before surgery were as follows: tiredness (97.8% of patients), weakness (94.6%), forgetfulness (94.6%), mood changes (90%), feeling “blue”/depression (88%), joint pains (83.3%), headaches (80.2%), constant irritability (77.2%), bone pains (75%), thirst (70.7%) and trouble getting out of a chair (67.4%). The half of the patients had moderate-to-severe (≥ 40 scores) tiredness, weakness, joint pains, forgetfulness, as well as mood changes. Post-operative QoL changes were analysed in the group of 72 patients. After surgery there was significant improvement in QoL by all scales of SF-36 questionnaire, excluding bodily pain, and the PHPQoL total score (GEE, p < 0.01) as compared with their values before surgery. Also severity of tiredness, mood changes, weakness and forgetfulness significantly decreased after surgery as compared to their baseline values (GEE, p < 0.05). Decreased mental component of QoL by PHPQoL (OR = 0.927, 95%CI = 0.874–0.984, p = 0.013) predicted improved QoL after surgery. Conclusions: Patients with PHPT demonstrated significantly impaired QoL in physical, psychological and social functioning as well experienced a wide profile of common PHPT symptoms. Successful PTX was accompanied with remarkable QoL improvement and decrease in subjective symptoms for at least 24 months after surgery.

15 November 2021 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
DRD. V. Rebrova
D. V. Rebrova
NVN. V. Vorokhobina
N. V. Vorokhobina
EIEvgeny N. Imyanitov
Evgeny N. Imyanitov
ВРВ. Ф. Русаков
В. Ф. Русаков
LKL. M. Krasnov
L. M. Krasnov
JFJu. N Fedotov
Ju. N Fedotov
The widespread introduction of genetic testing in recent years has made it possible to determine that more than a third of cases of pheochromocytomas and paragangliomas (PPPGs) are caused by germline mutations. Despite the variety of catecholamine-producing tumors manifestations, there is a sufficient number of clinical and laboratory landmarks that suggest a hereditary genesis of the disease and even a specific syndrome. These include a family history, age of patient, presence of concomitant conditions, and symptoms of the disease. Considering that each of the mutations is associated with certain diseases that often determine tactics of treatment and examination of a patient, e.g. high risk of various malignancies. Awareness of the practitioner on the peculiarities of the course of family forms of PPPGs will allow improving the tactics of managing these patients.The article provides up-to-date information on the prevalence of hereditary PPPGs. The modern views on the pathogenesis of the disease induced by different mutations are presented. The main hereditary syndromes associated with PPPGs are described, including multiple endocrine neoplasia syndrome type 2A and 2B, type 1 neurofibromatosis, von Hippel-Lindau syndrome, hereditary paraganglioma syndrome, as well as clinical and laboratory features of the tumor in these conditions. The main positions on the necessity of genetic screening in patients with PPPGs are given.

7 April 2023 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
ECEvgeny L. Choynzonov
Evgeny L. Choynzonov
IRI. V. Reshetov
I. V. Reshetov
SIS. A. Ivanov
S. A. Ivanov
APA. P. Polyakov
A. P. Polyakov
MKM. A. Kropotov
M. A. Kropotov
EKE. V. Kostromina
E. V. Kostromina
The article presents a draft of clinical recommendations for the diagnosis and treatment of differentiated thyroid cancer in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.